The authorisation referred to in Article D. 1221-58 may be issued to the Etablissement Français du Sang for the importation of blood or its components intended for the preparation of labile blood products within the framework of an international agreement providing for cross-border cooperation. By way of derogation from the provisions of article D. 1221-60 and article D. 1221-61, these imports may be authorised if the blood samples or its components do not meet the requirements of section II of this chapter, provided that the Etablissement Français du Sang undertakes to carry out the tests and analyses provided for in section II of this chapter immediately after importation and that it provides evidence that all safety guarantees concerning the transport and handling of these products have been taken.